When a pregnant woman is not properly screened or monitored for gestational diabetes, the consequences can extend far beyond elevated blood sugar. Uncontrolled maternal glucose fuels excessive fetal growth—a condition called macrosomia—that dramatically raises the risk of a traumatic delivery. Understanding gestational diabetes malpractice and the macrosomia risks that flow from screening and monitoring failures is critical for families whose newborns were injured at birth.
This article provides general legal information; consult a licensed Illinois attorney for advice specific to your situation.
The Standard of Care: Universal Screening at 24–28 Weeks
The American College of Obstetricians and Gynecologists (ACOG) Practice Bulletin 190 establishes universal screening for gestational diabetes mellitus (GDM) using a glucose challenge test or a two-step approach culminating in a 100-gram oral glucose tolerance test (OGTT) between 24 and 28 weeks of gestation. This is not optional—it is the national standard of obstetric care. The American Diabetes Association (ADA) Standards of Care in Diabetes reinforces this protocol and sets specific A1c and fasting glucose targets for pregnant patients identified as diabetic or pre-diabetic.
When a provider skips the OGTT, fails to order follow-up testing after an abnormal glucose challenge, or documents the test but never communicates results to the patient, they have deviated from this standard. If that deviation leads to uncontrolled gestational diabetes and fetal macrosomia, the legal foundation for a malpractice claim is present.
Glucose Monitoring Gaps: What Goes Wrong After Diagnosis
A missed diagnosis is only one way gestational diabetes malpractice occurs. Many cases arise after a correct diagnosis is made but proper management is never implemented. Under ACOG Practice Bulletin 190 and ADA pregnancy guidance, patients diagnosed with GDM require structured glucose monitoring protocols—typically fasting and one- or two-hour postprandial readings—combined with dietary counseling and, when diet alone is insufficient, insulin or oral medication therapy.
Monitoring failures that may support a malpractice claim include: failure to prescribe a glucose monitor or educate the patient on how to use it; failure to set individualized glucose targets aligned with ADA benchmarks; failure to escalate to pharmacologic treatment when self-monitored readings remain consistently elevated; and failure to follow up at appropriate intervals throughout the third trimester. Each of these gaps allows maternal hyperglycemia to persist, giving the fetus the continuous glucose supply that drives macrosomic growth.
Fetal Macrosomia: The Risk That Accumulates in the Third Trimester
Macrosomia—commonly defined as an estimated fetal weight exceeding 4,000 to 4,500 grams—is a foreseeable and well-documented consequence of uncontrolled gestational diabetes. ACOG Practice Bulletin 190 addresses delivery planning for suspected macrosomia, including the use of ultrasound biometry in the third trimester to estimate fetal weight and the consideration of planned cesarean delivery when certain weight thresholds are met or when clinical risk factors are present.
When a provider knows or should know that a patient has poorly controlled GDM yet fails to order serial growth ultrasounds, fails to document a macrosomia risk assessment, or proceeds with vaginal delivery without adequately counseling the family about cesarean alternatives, those decisions may fall below the standard of care. The resulting delivery complications—including brachial plexus injuries—trace directly to the prenatal management failures, not just to events in the delivery room.
Delivery Planning Failures and Their Legal Significance
Proper prenatal management of GDM culminates in a delivery plan tailored to the individual patient’s glucose control history and ultrasound findings. ACOG guidelines require providers to discuss risks, document informed consent, and revisit the delivery plan as the pregnancy progresses. A plan that ignores documented macrosomia or that schedules induction without adjusting for fetal size reflects a systemic failure that begins at screening and compounds with each missed intervention.
If your child suffered a brachial plexus or nerve injury during delivery, the prenatal care record is often as important as the delivery record. Families dealing with those outcomes should review our overview of Erb’s palsy birth injury claims to understand how delivery complications and prenatal negligence intersect in Illinois litigation.
Illinois Statute of Limitations for Gestational Diabetes Malpractice
Medical malpractice claims in Illinois are governed by 735 ILCS 5/13-212, which sets a two-year statute of limitations running from the date the claimant knew or reasonably should have known of the injury. For birth injury cases, Illinois also recognizes a separate limitations period for minor plaintiffs: under 735 ILCS 5/13-212(b), actions on behalf of a minor must generally be filed before the minor reaches age eight, providing a longer window than the two-year adult period. These deadlines are strict. Missing either deadline forfeits the right to compensation regardless of how strong the underlying case is.
Because gestational diabetes malpractice often involves a chain of events—missed screening at 24 weeks, inadequate monitoring throughout the third trimester, and a preventable delivery injury—identifying exactly when the limitations clock began to run requires careful legal analysis. An experienced Illinois birth injury attorney can review prenatal records, delivery documentation, and expert opinion to determine which acts of negligence are timely and which claims may be at risk.
What Evidence Supports a Gestational Diabetes Malpractice Claim
A successful claim in this area typically rests on four categories of evidence. First, the prenatal chart must show the absence or inadequacy of GDM screening—a missing OGTT order, no result documented in the medical record, or a result that was never communicated. Second, glucose monitoring logs or the absence of such logs demonstrate whether the provider implemented or tracked the management protocol. Third, third-trimester ultrasound records—or the absence of growth scans—show whether macrosomia was recognized and addressed. Fourth, delivery documentation reveals whether the clinical team had the information needed to make a safe delivery decision and whether that decision conformed to ACOG standards for suspected macrosomia.
Expert witnesses—typically board-certified obstetricians and maternal-fetal medicine specialists—review these records against ACOG Practice Bulletin 190 and ADA pregnancy guidelines to articulate exactly where care fell short and how that deviation caused the infant’s injury. This expert foundation is required for any Illinois medical malpractice claim under 735 ILCS 5/2-622, which mandates a written report from a qualified health professional before a lawsuit can proceed.
Talk to a Chicago Attorney — Free Consultation
If your child was injured during delivery and you believe gestational diabetes was mismanaged during your pregnancy, the attorneys at Phillips Law Offices are ready to help. Call (312) 346-4262 or contact us online for a free, no-obligation consultation.